Pitt Shield

Safety evaluation of a clinical focused ultrasound system for neuronavigation guided blood-brain barrier opening in non-human primates.

Authors: Pouliopoulos AN, Kwon N, Jensen G, Meaney A, Niimi Y, Burgess MT, Ji R, McLuckie AJ, Munoz FA, Kamimura HAS, Teich AF, Ferrera VP, Konofagou EE

An emerging approach with potential in improving the treatment of neurodegenerative diseases and brain tumors is the use of focused ultrasound (FUS) to bypass the blood-brain barrier (BBB) in a non-invasive and localized manner. A large body of pre-clinical work has paved the way for the gradual clinical implementation of FUS-induced BBB opening. Even though the safety profile of FUS treatments in rodents has been extensively studied, the histological and behavioral effects of clinically relevant BBB opening in large animals are relatively understudied. Here, we examine the histological and behavioral safety profile following localized BBB opening in non-human primates (NHPs), using a neuronavigation-guided clinical system prototype. We show that FUS treatment triggers a short-lived immune response within the targeted region without exacerbating the touch accuracy or reaction time in visual-motor cognitive tasks. Our experiments were designed using a multiple-case-study approach, in order to maximize the acquired data and support translation of the FUS system into human studies. Four NHPs underwent a single session of FUS-mediated BBB opening in the prefrontal cortex. Two NHPs were treated bilaterally at different pressures, sacrificed on day 2 and 18 post-FUS, respectively, and their brains were histologically processed. In separate experiments, two NHPs that were earlier trained in a behavioral task were exposed to FUS unilaterally, and their performance was tracked for at least 3 weeks after BBB opening. An increased microglia density around blood vessels was detected on day 2, but was resolved by day 18. We also detected signs of enhanced immature neuron presence within areas that underwent BBB opening, compared to regions with an intact BBB, confirming previous rodent studies. Logistic regression analysis showed that the NHP cognitive performance did not deteriorate following BBB opening. These preliminary results demonstrate that neuronavigation-guided FUS with a single-element transducer is a non-invasive method capable of reversibly opening the BBB, without substantial histological or behavioral impact in an animal model closely resembling humans. Future work should confirm the observations of this multiple-case-study work across animals, species and tasks.

Introduction

Purpose Drug delivery with BBB opening
Study Objective To evaluate the histological and behavioral safety profile following a single procedure of focused ultrasound-mediated blood–brain barrier opening using a clinical system prototype in a non-human primate model.
Animal model / Human subject Rhesus macaques, 7.5 ± 0.5 years old
Disease model Healthy
MRI or image guidance method Neuronavigation-guided
Targeted brain region(s) Prefrontal Cortex (Pfc)

Outcomes and Safety

Summary of Outcomes Neuronavigation-guided FUS successfully and reversibly opened the BBB in the prefrontal cortex of macaques at pressures of 200 and 400 kPa. The procedure caused no lasting behavioral deficits and only a short-lived immune response that resolved by day 18.
Duration of biological effect 18 days
Safety-related matter The procedure induced a transient immune response and minor focal edema that fully resolved by day 18, with no cognitive deterioration or acute hemorrhage observed.

Brain Region

Ultrasound Parameters

Ultrasound instrument Single-element transducer (neuronavigation-guided clinical system prototype)
FUS Frequency 0.25 MHz
FUS Pressure 200 kPa and 400 kPa
FUS Mode pulsed
Pulse duration 10 ms
Duration of a single FUS session 2 min
Focal Characteristics Focal depth: 49 mm
Treatment frequency Single session

We are open to feedback. If you see a mistake or have a suggestion, please contact us.

← Back to Search